Period Ending | Mar 28, 2013 | Dec 27, 2012 |
---|
Total Revenue
|
821,000
|
809,000
| Cost of Revenue | 341,000 | 336,000 | |
Gross Profit
|
480,000
|
473,000
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
|
Selling General and Administrative | 306,000 | 287,000 |
|
Non Recurring |
-
|
-
|
|
Others |
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
| | |
Operating Income or Loss
|
174,000
|
186,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 16,000 | 6,000 |
|
Earnings Before Interest And Taxes | 190,000 | 192,000 |
|
Interest Expense | 30,000 | 24,000 |
|
Income Before Tax | 160,000 | 168,000 |
|
Income Tax Expense | 53,000 | 63,000 |
|
Minority Interest |
-
|
-
|
|
|
|
Net Income From Continuing Ops | 107,000 | 105,000 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
|
Extraordinary Items |
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
|
Other Items |
-
|
-
| | |
Net Income
|
107,000
|
105,000
| Preferred Stock And Other Adjustments |
-
|
-
| |
Net Income Applicable To Common Shares
|
107,000
|
105,000
|
|